Dimdazenil

地达西尼

Report date: 2024/03/13 16:58:53
NME

Base Information

Drug NameDimdazenil
Drug Alias Name安达西尼EVT-201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor modulators
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsSleep Initiation and Maintenance DisordersSleep Wake Disorders
Global Approved IndicationsSleep Initiation and Maintenance Disorders
Approved Indications in ChinaSleep Initiation and Maintenance Disorders
Original Approved Country/TerritoryMainland China
Original Approved Date2023/11/28
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhejiang Jingxin Pharmaceutical Co Ltd
Inactive CompaniesEvotec Neurosciences Gmbh
Active IndicationsSleep Initiation and Maintenance DisordersSleep Wake Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksWikipedia